Switching From Ozempic to Mounjaro
Two different medicines, two different dose ladders, and one timeline that carries your whole history through the change.
Quick answer
Ozempic and Mounjaro are two different medicines with different FDA dose ladders, so there is no one-to-one conversion between them. Mounjaro restarts low at 2.5 mg while semaglutide is still leaving your body, so early side effects can return. Your prescriber sets the dose; MeAgain keeps your whole history on one timeline.
Ozempic (semaglutide) and Mounjaro (tirzepatide) are two different medicines with two different FDA dose schedules, so there is no official one-to-one conversion between them. Each has its own label ladder, Ozempic from 0.25 mg to a 2 mg maximum and Mounjaro from 2.5 mg to 15 mg, on different scales that are not a shared ranking. Your prescriber sets your Mounjaro starting dose and start date from your history. What does not reset is everything behind you. In MeAgain your weight trend, your logged side effects, and every dose date stay on one timeline through the switch, so you can watch your Ozempic levels ease off and Mounjaro build on the estimated medication-levels graph, and tell whether a rough first week is the dose climbing or just the change. That continuous record is the log you bring to your prescriber. 500K people track their GLP-1 with MeAgain, rated 4.8 stars across 23K App Store ratings.
Bottom line: This page is education, not medical advice. Medication choice, dose changes, and your start date belong with your prescriber or a licensed clinician. MeAgain works with any GLP-1, branded or compounded, wherever it is prescribed.
Key takeaways
Ozempic climbs four labeled steps from 0.25 mg to a 2 mg maximum; Mounjaro climbs six, from 2.5 mg to 15 mg. The scales do not line up and no row matches another, so there is no conversion to read: your Mounjaro starting dose comes from your prescriber weighing your Ozempic history, not from a table.
The label starts Mounjaro at 2.5 mg for the first four weeks so your body can adjust, which is why side effects you had already settled past, like nausea or constipation, can come back for a few weeks after the switch. That is expected, not a setback.
Switching does not empty your system overnight. Semaglutide carries the longer tail, about a one-week half-life and close to five weeks of clearing after your last Ozempic dose, so Mounjaro climbs while it fades and nothing resets on a single date.
Call your prescriber the same day for severe or lasting stomach pain, vomiting that will not stop, or yellowing of the skin or eyes. These are not part of a normal switch and need attention right away, whichever medicine you are on.
Tracking shots, side effects, weight, and food on one timeline carries your whole Ozempic history into Mounjaro, so you and your prescriber can see how your own body responded before and after the change.
How MeAgain Tracks You Through the Switch
01Watch One Medicine Fade and the Next Build
A switch from Ozempic is a long, slow handoff, not a clean swap. Semaglutide has about a one-week half-life and keeps leaving your body for roughly five weeks, so it is still fading while Mounjaro starts over at 2.5 mg and a second appetite signal comes online. The estimated medication-levels graph puts both on one timeline, the Ozempic line easing down as the Mounjaro line steps up. It is an estimate for tracking and education, not a dosing tool, but it turns those overlapping weeks into something you can actually read: where each medicine sits right now, and whether a heavy Tuesday is the new dose climbing or the old one still on board. Choose the medicine and dose, and the curve redraws itself around your real schedule instead of a guess.
02Rate Every Returning Symptom, Zero to Ten
Mounjaro opens at 2.5 mg and works its way up, so symptoms you had already outlasted on Ozempic can circle back for a few weeks while your body meets the new medicine. The move that helps is not bracing for them but writing them down. MeAgain tracks the 18 most common GLP-1 side effects plus unlimited custom symptoms, each on a 0 to 10 severity slider with the date, so a rough week turns into a curve you can watch flatten rather than a memory you argue with later. That record pulls double duty: it shows you whether week three is easier than week one, and it gives your prescriber a specific reading, which symptom, how strong, which days, instead of a vague sense that the start was hard.
03One Weight Line Across Both Medicines
Early weight on a switch swings for reasons that have little to do with Mounjaro itself: water moves, one heavy week of eating, the drop back to a 2.5 mg starting dose. That is why a single morning on the scale is the wrong thing to react to and the multi-week trend is the right one. MeAgain holds your weight on one continuous line across both medicines, so the low starting dose reads as a dip in context and a genuine plateau stands out clearly enough to raise with your prescriber. The line does not reset when the prescription does, so the months you logged on Ozempic stay part of the same picture. A dose that starts over is not progress starting over, and the trend is what keeps that honest.
04Walk In With the Whole Story, Not a Guess
The most valuable thing you carry into the next visit is not a conversion figure, because there is not one. It is your own account of the switch: your last Ozempic dose and date, how long you sat at each step, the side effects and how hard they hit, and how your weight actually moved. MeAgain holds all of it on one timeline, so you walk in with what you tracked rather than piecing months together on the spot. The app does not choose your medicine or your dose, that belongs to your prescriber, and it is not a substitute for the appointment. What it does is anchor the plan to what your body actually did, so the next step builds on facts instead of a hopeful hunch.
Ozempic to Mounjaro: What Actually Changes, and What Does Not
Why there is no one-to-one dose conversion
There is no official one-to-one conversion between Ozempic and Mounjaro because semaglutide and tirzepatide are different molecules on different scales. Ozempic climbs four labeled steps from 0.25 mg to a 2 mg maximum; Mounjaro climbs six, from 2.5 mg to 15 mg. A milligram of one is not a milligram of the other, and the numbers are not a ranking you can read across. Any chart that pairs an Ozempic dose with an equivalent Mounjaro dose is inventing a figure the labels never set, and following it could put you at the wrong dose.
Your prescriber picks your Mounjaro starting dose from your Ozempic history, how you tolerated it, and your goals, not from arithmetic. Each label ladder below is its own separate schedule, meant to be read top to bottom, never across to the other.
Official label schedules shown side by side. Rows are not equivalent doses and should not be read across. These are separate label schedules, not a switching instruction. Use the start date and dose your prescriber gave you.
Ozempic dose ladder (semaglutide)
Dose steps from the FDA Ozempic (semaglutide) prescribing information via DailyMed, Dosage and Administration, Section 2.2. Injection schedule only, and not a switching instruction.
| Dose step | Time at this step | Role in the label schedule |
|---|---|---|
| 0.25 mg | 4 weeks | Initiation dose for treatment start; not a maintenance dose. |
| 0.5 mg | at least 4 weeks | First maintenance dosage, reached after 4 weeks on 0.25 mg. The label's recommended maintenance dosages are 0.5 mg, 1 mg, and 2 mg. |
| 1 mg | at least 4 weeks | A maintenance dosage; may be reached after at least 4 weeks on 0.5 mg if additional glycemic control is needed. |
| 2 mg | maintenance | Highest maintenance dosage; the maximum recommended dosage is 2 mg once weekly. |
Mounjaro dose ladder (tirzepatide)
Dose steps from the FDA Mounjaro (tirzepatide) prescribing information via DailyMed, Dosage and Administration, Section 2.1. Injection schedule only, and not a switching instruction.
| Dose step | Time at this step | Role in the label schedule |
|---|---|---|
| 2.5 mg | 4 weeks | Treatment initiation dose; not a maintenance dose. |
| 5 mg | at least 4 weeks | Increase after 4 weeks on 2.5 mg. |
| 7.5 mg | at least 4 weeks | Increase in 2.5 mg increments after at least 4 weeks on the current dose. |
| 10 mg | at least 4 weeks | Increase in 2.5 mg increments after at least 4 weeks on the current dose. |
| 12.5 mg | at least 4 weeks | Increase in 2.5 mg increments after at least 4 weeks on the current dose. |
| 15 mg | ongoing | Maximum dosage for adults; pediatric patients 10 years and older stop at 10 mg once weekly. |
Half-life and timing facts
Half-life, time to peak level, and time to steady state are from each product's FDA label, Section 12.3. The last row is the label's own figure where the label states one, and otherwise a standard five-half-lives estimate noted in the cell. These describe one medicine's own timing; they are not a formula for overlapping two medicines.
| Timing measure | Ozempic (semaglutide) | Mounjaro (tirzepatide) |
|---|---|---|
| Elimination half-life | approximately 1 week | approximately 5 days |
| Time to peak level (Tmax) | 1 to 3 days post dose | 8 to 72 hours (median 24 hours) |
| Time to steady state | reached following 4 to 5 weeks of once-weekly administration | reached following 4 weeks of once-weekly administration |
| Time in the body after the last dose | present in the circulation for about 5 weeks after the last dose | essentially eliminated after about 25 days (roughly five half-lives) by the five-half-lives convention |
What the timing numbers mean
Read these as timing facts, not strength facts. Half-life measures how quickly a dose halves in your body, which is why semaglutide, at about a week, lingers for roughly five weeks after your last Ozempic shot instead of clearing at once. None of it predicts when appetite quiets or returns, which varies from person to person. Time to peak is when a dose hits its high point; steady state is when weekly doses stop accumulating. The Ozempic and Mounjaro half-life calculators linked below trace the whole fade one week at a time.
What to expect through the first weeks
The medicine changes, the weekly rhythm changes, and the dose steps back to the bottom even though your progress does not. Mounjaro starts at 2.5 mg for the first four weeks, so plan for a low opening step and a few weeks of re-adjustment while semaglutide keeps clearing in the background. Side effects you had left behind can return briefly before they settle. Whether Mounjaro quiets appetite more than Ozempic did, about the same, or less, is individual, and the two-signal action is no guarantee of a bigger result for you.
Most people arrive at this switch hopeful, having chosen it, and a reset to 2.5 mg can feel deflating until you remember it is simply how the label eases you on. If a cost or supply decision pushed the switch instead, a little frustration is fair. Either way the practical response is the same: start from your real Ozempic history, give the new medicine a full adjustment window, and let your prescriber set the pace.
Switching the other way: Mounjaro back to Ozempic
Going the other way, from Mounjaro back to Ozempic, the same ideas hold with the medicines reversed. Tirzepatide keeps leaving your body for about 25 days after your last Mounjaro dose, and Ozempic runs its own step-up from 0.25 mg toward a 2 mg maximum, so there is still nothing to convert across. Your prescriber sets the Ozempic starting dose and timing from your history rather than from your Mounjaro number. The re-adjustment, the side effects that can briefly return, and a single continuous record are just as useful when the medicines trade places.
Bring this to your prescriber
- The medicine, dose, and date of your most recent injection
- How long you have been at your current dose
- Side effects you have had, and how strong they were
- Other medicines and supplements you take
- The new medicine, dose, and start date your prescriber sets
- What to watch for, and when to check back in
Whichever way the switch goes, and whichever medicine you and your prescriber choose, the tracking works from day one and keeps the whole story on one timeline. MeAgain works with any GLP-1, branded or compounded, wherever it is prescribed.
For educational use only; this is not medical advice. There is no official one-to-one dose conversion between these medicines. Each has its own FDA-labeled schedule, shown here as separate label facts. Only your prescriber can choose your dose and start date. Do not use this page to change, start, or stop any medication.
Sources
- FDA Ozempic (semaglutide) prescribing information via DailyMed, Dosage and Administration and Clinical Pharmacology (Sections 2.2 and 12.3)
- FDA Mounjaro (tirzepatide) prescribing information via DailyMed, Dosage and Administration and Clinical Pharmacology (Sections 2.1 and 12.3)
- Frías JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). NEJM. 2021;385:503–515
- Rosenstock J et al. Efficacy and safety of tirzepatide monotherapy in type 2 diabetes (SURPASS-1). Lancet. 2021;398:143–155
- Marso SP et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). NEJM. 2016;375:1834–1844
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM. 2021;384:989–1002
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM. 2022;387:205–216
- Mayo Clinic: Semaglutide injection, description, dosing, and administration
- Drugs.com: Tirzepatide monograph, dosing, half-life, and administration
- American Society of Anesthesiologists: Multi-Society Clinical Practice Guidance on GLP-1 medicines and elective procedures (2024)
The Switch Is One Moment. The Tracking Is the Rest.
One Record Across Both Medicines
Choosing to move to Mounjaro settles one decision; living through the switch is the part that lasts. That is where a real record earns its place, across shot days, side effects, meals, water, and a weight trend measured in months. Reviewers tend to describe exactly that once the tracking becomes routine.
I have been able to lose over 100 pounds tracking everything with this app. It was great to be able to see where I was overeating. Tracking my medication in the same app is convenient. It covers all my nutrition needs.
That is the pattern once the switch is behind you. Ozempic or Mounjaro is one moment of the week; the food, the symptoms, and the weight trend around it are where the routine actually lives.
The same app follows you across the whole GLP-1 category instead of tying you to one brand. Shot-day countdowns, a fresh injection site each week, symptom severity from 0 to 10, protein and food logging, and an unbroken weight line all stay put. Keep taking Ozempic or move up to Mounjaro, and the tracking fits the change rather than forcing a restart.
What Our Users Say
“I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication. The little capybara widget is a great visual to help me know what my body needs.”
“This app does exactly what I needed with tracking shots… location, time, amount, current medication level, and reminders for the next one. That plus weight progress is all I needed, and after trying at least 5 others this was the only one that did it in a clean, logical way- and didn't cost a fortune!”
“I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else. The app is totally worth the cost and it's been perfect for me.”
“I've been on my MJ journey since September 2025. Seeing my food intake has made a huge difference. Also, reviewing my shot locations has helped me remember to rotate. I have recommended this app to my friends who have also started their own journeys!”
“I love tracking water, protein and fiber on the app. It's really cool it's able to pull my weight and steps too. Add the widget to you phone screen if you do get it, I love that.”
Learn More About Switching GLP-1 Medicines
Wegovy vs Mounjaro Side Effects: Patient Guide
Learn the key differences in Wegovy vs Mounjaro side effects to help you make informed decisions about weight loss treatment options.
Switching From Ozempic to Mounjaro - FAQs
No, and no dependable one exists. Semaglutide and tirzepatide are different medicines on different scales: Ozempic runs 0.25 mg to a 2 mg maximum across four labeled steps, Mounjaro runs 2.5 mg to 15 mg across six, and the milligram numbers are not a shared ranking. Pairing an Ozempic dose with a Mounjaro one on some chart just invents a number the labels never set, and it can steer you to the wrong dose. Your prescriber sets your Mounjaro starting dose from your Ozempic history, your tolerance, and your goals. The label opens most people at 2.5 mg on purpose, giving the body four weeks to settle before the first step up.
Your Journey Back to You,
One Day at a Time
Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.